Theolytics Employee Directory
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Theolytics is a biotechnology company based in Oxford, Oxfordshire, focused on developing oncolytic therapies that use viruses to combat cancer. Its core platform supports phenotypic screening to identify and optimize virus-based candidates that can be delivered intravenously and tailored for specific patient populations. The company maintains an internal pipeline spanning both solid and liquid tumors and pursues selective partnerships to broaden and accelerate development. In 2026, Theolytics announced that its Phase 1 OCTOPOD-IP trial of THEO-260 for ovarian cancer would be presented as a Trials in Progress poster at ASCO, highlighting ongoing clinical evaluation of its oncolytic immunotherapy approach. The organization operates within the oncolytic immunotherapy field and collaborates to expand its pipeline from internal programs to external partnerships, while remaining based in Oxford.